Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ASMB holding history

Assembly Biosciences, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ASMB overviewAll 13F holders of ASMBFull Q2 2026 holdings

Shares (Q2 2026)
41,806
Value
$1.15M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ASMB by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202641,806$1.15M<0.1%+41,442+11,385.2%AddedHolders
Q1 2026364$10.1K<0.1%−9,415−96.3%ReducedHolders
Q4 20259,779$332.6K<0.1%−5,984−38.0%ReducedHolders
Q3 202515,763$403.5K<0.1%+12,830+437.4%AddedHolders
Q2 20252,933$53.1K<0.1%+2,166+282.4%AddedHolders
Q1 2025767$7.33K<0.1%−5,780−88.3%ReducedHolders
Q4 20246,547$103.3K<0.1%+5,246+403.2%AddedHolders
Q3 20241,301$19.7K<0.1%−1,648−55.9%ReducedHolders
Q2 20242,949$40.5K<0.1%−286−8.8%ReducedHolders
Q1 20243,235$43.0K<0.1%+1,221+60.7%AddedConverted for a 1-for-12 splitHolders
Q4 202324,164$19.8K<0.1%+24,164NewHolders
Q2 20230$00.0%−10,601−100.0%Sold outHolders
Q1 202310,601$8.90K<0.1%−13,406−55.8%ReducedHolders
Q4 202224,007$31.2K<0.1%+12,576+110.0%AddedHolders
Q3 202211,431$19.0K<0.1%+10,821+1,773.9%AddedHolders
Q2 2022610$1.00K<0.1%−3,138−83.7%ReducedHolders
Q1 20223,748$8.00K<0.1%−2,574−40.7%ReducedHolders
Q4 20216,322$15.0K<0.1%−137,311−95.6%ReducedHolders
Q3 2021143,633$500.0K<0.1%+1,486+1.0%AddedHolders
Q2 2021142,147$552.0K<0.1%+126,565+812.3%AddedHolders
Q1 202115,582$72.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.